Scaling up AIDS treatment: what is the potential impact and what are the risks?
Lamptey
Peter
P
Institute for HIV/AIDS, Family Health International, Arlington, Virginia, USA. plamptey@fhi.org
Wilson
David
D
D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D044966:Anti-Retroviral Agents / Q000191:economics* / Q000627:therapeutic use*; D003363:Cost Control; D016527:Drug Costs; D014943:Global Health; D006801:Humans; D008403:Mass Screening; D011315:Preventive Medicine; D040841:Resource Allocation; D012307:Risk Factors
D044966:Anti-Retroviral Agents
PLoS Med. 2005 Jan;2(1):e16
15647780